I'm 99.9% sure that the board or prima including Dr frazer especially ! Will have an indication on how Cvac has performed over those ph2b trials. Otherwise why would Dr Goh be presenting the data in Canada in October to a large conference of people. If prima had ANY doubt on the effectiveness of Cvac IMO this wouldn't be planned. I honestly can't see him presenting in October "unfortunately The clinical data on the patients showed Cvac not to be effective and we are extremely disappointed by this". He wouldn't want to make a fool of himself and the company. I'm confident and looking forward to CVACtober! (well it is going to be Primas month).
dr goh - october interim data, page-3
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.060(20.3%) |
Mkt cap ! $515.6M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.5¢ | 33.5¢ | $6.427M | 18.03M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 133736 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |